A Devotion to Research
Dr. Korenfeld has been doing research since 8th grade, when he received his first grant from the University of Missouri-St. Louis to study the behavior of fruit flies based upon the color of their eyes. A subsequent grant was obtained from Washington University to study Bone and Mineral Metabolism while he was in high school. Because he achieved the highest ranking in Immunology while matriculating at the Washington University School of Medicine, Dr. Korenfeld was awarded another grant to study new HLA antigen types under the auspices of the Howard Hughes Medical Institute. Since his residency in ophthalmology, all of his research has shifted from “bench top” research to clinical trial research. He has been the Principal Investigator for over 70 FDA-approved clinical trials for both pharmaceuticals and ophthalmic devices, and has been involved the development of most of the eye drops that you can currently purchase at the pharmacy. Dr. Korenfeld is actively engaged in clinical trial work, and is currently performing studies in glaucoma, cataract surgery (intraocular lens implants and drugs used with cataract surgery), dry eye, blepharitis, inflammation, infection, and allergic eye diseases. He has also started to perform clinical trials for esthetic conditions, like the use of Latisse for sparse eyelashes and eyebrows.